Uridine_Diphosphate

Uridine_Diphosphate

SCHEMBL667655

O=C[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO.O=c1ccn([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]2O)c(=O)[nH]1

nearest known ligand 0.69

Full drug profile on Sugi Atlas →

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
P2RY6 Q15077 8/20 0.69
P2RY2 P41231 12/20 0.68
P2RY4 P51582 7/20 0.68
P2RY14 Q15391 6/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Uridine_Diphosphate SCHEMBL20553195 1.00 P2RY6 (0.69) P2RY6P2RY2P2RY4P2RY14
Uridine_Diphosphate SCHEMBL454080 1.00 P2RY6 (0.69) P2RY6P2RY2P2RY4P2RY14
Uridine_Diphosphate SCHEMBL4311732 1.00 P2RY6 (0.69) P2RY6P2RY2P2RY4P2RY14
Uridine_Diphosphate SCHEMBL27785901 1.00 P2RY6 (0.69) P2RY6P2RY2P2RY4P2RY14
Uridine_Diphosphate SCHEMBL23923917 0.99 P2RY6 (0.68) P2RY6P2RY2P2RY4P2RY14
Uridine_Diphosphate SCHEMBL8740673 0.99 P2RY6 (0.68) P2RY6P2RY2P2RY4P2RY14
Uridine_Diphosphate SCHEMBL28303416 0.99 P2RY6 (0.68) P2RY6P2RY2P2RY4P2RY14
Uridine_Diphosphate SCHEMBL27780277 0.98 P2RY6 (0.69) P2RY6P2RY2P2RY4P2RY14
Uridine_Diphosphate SCHEMBL4295328 0.98 P2RY6 (0.69) P2RY6P2RY2P2RY4P2RY14
Uridine_Diphosphate SCHEMBL27463201 0.97 P2RY6 (0.65) P2RY6P2RY2P2RY4P2RY14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 694 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-121271994-B Preparation method and application of alpha-2, 3 sialyltransferase-mediated sugar chain site-directed conjugated antibody drug conjugate Wuhan Tangzhi Pharmaceutical Co.,Ltd. (CN) 2026-05-26 CN claimed
CN-122012453-A Polyphosphate kinase BsPPK mutant and construction and application of production bacteria thereof 中国海洋大学 2026-05-12 CN claimed
US-20250345420-A1 CANCER IMMUNOTHERAPIES TO PROMOTE HYPERACUTE REJECTION UNIV CORNELL (US) 2025-11-13 US claimed
CN-120020261-A Method for total synthesis of N-glycan 中国科学院上海药物研究所 2025-05-20 CN claimed
EP-4531917-A1 CANCER IMMUNOTHERAPIES TO PROMOTE HYPERACUTE REJECTION Cornell University (US) 2025-04-09 EP claimed
CN-119677538-A Cancer immunotherapy for promotion of hyperacute rejection 康奈尔大学 2025-03-21 CN claimed
CN-119432954-A Method for preparing multi-branched O-GalNAc oligosaccharide 山东大学 2025-02-14 CN claimed
US-20240418701-A1 SINGLE MOLECULE IDENTIFICATION WITH A REACTIVE HETERO-NANOPORE NANJING UNIVERSITY (CN) 2024-12-19 US claimed
US-20240279703-A1 Sialylated Glycoproteins MOMENTA PHARMACEUTICALS INC (US) 2024-08-22 US claimed
EP-4413379-A1 SINGLE MOLECULE IDENTIFICATION WITH A REACTIVE HETERO-NANOPORE Nanjing University (CN) 2024-08-14 EP claimed
CN-1208440-A Process for producing sugar nucleotides and complex carbohydrates KYOWA HAKKO KOGYO KK (JP) 1999-02-17 CN claimed
CN-1207135-A Process for producing sugar nucleotides and complex carbohydrates KYOWA HAKKO KOGYO KK (JP) 1999-02-03 CN claimed
EP-0886639-A1 SIALYL-LEWISa AND SIALYL-LEWISx EPITOPE ANALOGUES GlycoTech Corp. (US) 1998-12-30 EP claimed
WO-1998058964-A1 METHODS AND COMPOSITIONS FOR GALACTOSYLATED GLYCOPROTEINS GENENTECH, INC. (US) 1998-12-30 WO claimed
EP-0861902-A1 PROCESSES FOR PRODUCING SUGAR NUCLEOTIDES AND COMPLEX CARBOHYDRATES KYOWA HAKKO KOGYO CO., LTD. (JP) 1998-09-02 EP claimed
WO-1997047641-A1 NUCLEOTIDE SUGAR TRANSPORTERS AND USES THEREOF UNIVERSITY OF MASSACHUSETTS (US) 1997-12-18 WO claimed
EP-0801684-A1 PROCESS FOR THE COMPLETE REMOVAL OF PROTECTIVE GROUPS ON NUCLEOSIDE DIPHOSPHATE AND TRIPHOSPHATE SUGARS Novartis AG (CH) 1997-10-22 EP claimed
WO-1997028174-A1 SIALYL-LEWISa AND SIALYL-LEWISx EPITOPE ANALOGUES NOVARTIS AG (CH) 1997-08-07 WO claimed
WO-1996024683-A1 PROCESS FOR THE COMPLETE REMOVAL OF PROTECTIVE GROUPS ON NUCLEOSIDE DIPHOSPHATE AND TRIPHOSPHATE SUGARS NOVARTIS AG (CH) 1996-08-15 WO claimed
US-4132600-A MEASURING LEVEL OF GALACTOSYL TRANSFERASE ACTIVITY MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 1979-01-02 US claimed